Comparison of the severity of metabolic, liver and cardiovascular damage in NAFLD patients attending the hepatology clinic over the last three decades.

doi:10.1016/j.dld.2023.07.009

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Comparison of the severity of metabolic, liver and cardiovascular damage in NAFLD patients attending the hepatology clinic over the last three decades.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver - 1 Jan 2024

Lombardi Rosa, Colavolpe Lucia, Alletto Francesca, Cespiati Annalisa, Fatta Erika, Bertelli Cristina, Cinque Felice, Pisano Giuseppina, Pulixi Edoardo, Francione Paolo, Maffi Gabriele, Iuculano Federica, Dongiovanni Paola, Meroni Marica, Burdick Larry, Bignamini Daniela, Maggioni Marco, Valenti Luca, Fargion Silvia, Fracanzani Anna Ludovica

Abstract excerpt

BACKGROUND AND AIMS: NAFLD prevalence is increasing worldwide. AIM: to assess whether severity of hepatic, metabolic and cardiovascular (CV) disease changed over time. METHODS: 422 NAFLD patients (388 biopsy proven and 34 clinical cirrhosis) diagnosed between 1990 and 2021 and subdivided according to decade of presentation. Metabolic parameters, early atherosclerosis (carotid plaques at Doppler ultrasound),...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Atherosclerosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus

Share to PNPLA3 gene

Share to Liver

Share to Liver Cirrhosis

Share to Non-alcoholic Fatty Liver Disease

Share to Obesity

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed

Identifiers

PMID: 37507284
DOI: 10.1016/j.dld.2023.07.009

Genes

PNPLA3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of the severity of metabolic, liver and cardiovascular damage in NAFLD patients attending the hepatology clinic over the last three decades.PMID 37507284Read ↗

Nonalcoholic Fatty Liver Disease 2020: The State of the Disease.Semantic proximity Read ↗

Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies.Semantic proximity Read ↗

Natural History of NAFLDSemantic proximity Read ↗

Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and BeyondSemantic proximity Read ↗

PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease.Semantic proximity Read ↗

NAFLD-NASH: An Under-Recognized Epidemic.Semantic proximity Read ↗

Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population.Semantic proximity Read ↗

Effect of common genetic variants on the risk of cirrhosis in non‐alcoholic fatty liver disease during 20 years of follow‐upSemantic proximity Read ↗

Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive AnalysisSemantic proximity Read ↗

Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management.Semantic proximity Read ↗

Impact Of Thyroid Dysfunction And Diabetes On Fibrosis And Steatosis Stages In Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.